Farnesyltransferase inhibitor treatment restores chromosome territory positions and active chromosome dynamics in Hutchinson-Gilford progeria syndrome cells
Open Access
- 1 January 2011
- journal article
- Published by Springer Science and Business Media LLC in Genome Biology
- Vol. 12 (8), R74
- https://doi.org/10.1186/gb-2011-12-8-r74
Abstract
Copyright @ 2011 Mehta et al.; licensee BioMed Central Ltd. This article has been made available through the Brunel Open Access Publishing Fund. ud This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BACKGROUND: Hutchinson-Gilford progeria syndrome (HGPS) is a premature ageing syndrome that affects children leading to premature death, usually from heart infarction or strokes, making this syndrome similar to normative ageing. HGPS is commonly caused by a mutation in the A-type lamin gene, LMNA (G608G). This leads to the expression of an aberrant truncated lamin A protein, progerin. Progerin cannot be processed as wild-type pre-lamin A and remains farnesylated, leading to its aberrant behavior during interphase and mitosis. Farnesyltransferase inhibitors prevent the accumulation of farnesylated progerin, producing a less toxic protein. RESULTS: We have found that in proliferating fibroblasts derived from HGPS patients the nuclear location of interphase chromosomes differs from control proliferating cells and mimics that of control quiescent fibroblasts, with smaller chromosomes toward the nuclear interior and larger chromosomes toward the nuclear periphery. For this study we have treated HGPS fibroblasts with farnesyltransferase inhibitors and analyzed the nuclear location of individual chromosome territories. We have found that after exposure to farnesyltransferase inhibitors mis-localized chromosome territories were restored to a nuclear position akin to chromosomes in proliferating control cells. Furthermore, not only has this treatment afforded chromosomes to be repositioned but has also restored the machinery that controls their rapid movement upon serum removal. This machinery contains nuclear myosin 1β, whose distribution is also restored after farnesyltransferase inhibitor treatment of HGPS cells. CONCLUSIONS: This study not only progresses the understanding of genome behavior in HGPS cells but demonstrates that interphase chromosome movement requires processed lamin A.This work was funded by an ORSAS award and the Brunel Progeria Research FundThis publication has 62 references indexed in Scilit:
- Cytoskeletal and nuclear (“nucleoskeletal”) intermediate filaments and diseaseMolecular Biology of the Cell, 2011
- Association of adipogenic genes with SC-35 domains during porcine adipogenesisChromosome Research, 2010
- Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerinHuman Molecular Genetics, 2010
- Diseases of the Nuclear EnvelopeCold Spring Harbor Perspectives in Biology, 2010
- A progeria mutation reveals functions for lamin A in nuclear assembly, architecture, and chromosome organizationProceedings of the National Academy of Sciences of the United States of America, 2009
- The spatial repositioning of adipogenesis genes is correlated with their expression status in a porcine mesenchymal stem cell adipogenesis model systemChromosoma, 2009
- Exploring the effects of a dysfunctional nuclear matrixBiochemical Society Transactions, 2008
- A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse modelProceedings of the National Academy of Sciences of the United States of America, 2008
- Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature agingProceedings of the National Academy of Sciences of the United States of America, 2006
- The nuclear lamina comes of ageNature Reviews Molecular Cell Biology, 2005